MRNA and miRNA expression patterns associated to pathways linked to metal mixture health effects

Gene

Volumn 533, Issue 2, 2014, Pages 508-514

  Martinez Pacheco M ^a   Hidalgo Miranda, A ^b   Romero Cordoba S ^b   Valverde, M ^a   Rojas, E ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

Author keywords

Bioinformatics; Disease; Metal; MicroRNA; MRNA

Indexed keywords

ARSENATE SODIUM; CADMIUM CHLORIDE; MESSENGER RNA; MICRORNA;

ANIMAL CELL; ARTICLE; BONE DISEASE; CARDIOVASCULAR DISEASE; CELL DEATH; CELL GROWTH; CELL MATURATION; CELL MOTION; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE COURSE; DOWN REGULATION; EXPOSURE; GENE EXPRESSION; GENETIC DISORDER; INFLAMMATORY DISEASE; MALIGNANT NEOPLASTIC DISEASE; METAL EXPOSURE; MOUSE; MUSCLE DISEASE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; UPREGULATION;

°C; ΜM; ADCYAP1; ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 1; AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY; AL(2)(SO(4))(3); ALUMINIUM SULFATE; ARSENIC; ARSENIC TRIOXIDE; AS; AS(2)O(3); ATSDR; BIOINFORMATICS; C-MOS; CA; CADMIUM; CADMIUM CHLORIDE; CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE II ALPHA; CALIFORNIA; CALPONIN 1; CAMK2A; CARBON DIOXIDE; CASP3; CASPASE 3; CCNI; CD; CDCL(2); CDNA; CHLORIDE CHANNEL CLIC-LIKE 1; CLCC1; CNN1; CNTD1; CO(2); COMPLEMENTARY DEOXYRIBONUCLEIC ACID; CT; CYCLE THRESHOLD; CYCLIN I; CYCLIN N-TERMINAL DOMAIN CONTAINING 1; CYP1A1; CYTOCHROME P450 FAMILY 1 SUBFAMILY A POLYPEPTIDE 1; DE; DEGREE CELSIUS; DELAWARE; DEOXYRIBONUCLEIC ACID; DHFR; DIHYDROFOLATE REDUCTASE; DISEASE; DMEM; DNA; DNAJ (HSP40) HOMOLOG SUBFAMILY B MEMBER 4; DNAJB4; DULBECCO'S MODIFIED EAGLE'S MINIMUM ESSENTIAL MEDIUM; EDEM3; EDTA; ER DEGRADATION ENHANCER MANNOSIDASE ALPHA-LIKE 3; ETHYLENEDIAMINETETRAACETIC ACID; FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG; FBS; FC; FE(2)SO(4); FETAL BOVINE SERUM; FGFR; FGFRL1; FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR-LIKE 1; FOLD CHANGE; FOS; FRIZZLED FAMILY RECEPTOR 4; FRIZZLED FAMILY RECEPTOR 6; FZD4; FZD6; GLO1; GLYOXALASE I; H; HEPG2; HN; HOMO SAPIENS BONE OSTEOSARCOMA CELL LINE; HOUR; HUMAN HEPATOCELLULAR G2 CELL LINE; HUMAN NEURAL GLIOMA CELL LINE; INGENUITY PATHWAY ANALYSIS; IPA; IRON SULFATE; KCND2; LAMC1; LAMININ GAMMA 1; LEAD; LEAD ACETATE; LOG; LOGARITHM; M. MUSCULUS; MADD; MAP-KINASE ACTIVATING DEATH DOMAIN; MARYLAND; MBNL1; MD; MESSENGER RNA; METAL; MG63; MGD; MICROMOLAR; MICRORNA; MIRNA; MOLONEY MURINE SARCOMA ONCOGENE; MOUSE GENOME DATABASE; MRNA; MTPN; MUS MUSCULUS; MUSCLEBLIND-LIKE SPLICING REGULATOR 1; MYOTROPHIN; NAASO(2); NANOMOLAR; NAVO(3); NCAM1; NDFIP1; NEDD4 FAMILY INTERACTING PROTEIN 1; NEURAL CELL ADHESION MOLECULE 1; NEW YORK; NICKEL SULFATE; NISO(4); NK6 HOMEOBOX 1; NKX6-1; NM; NUCLEOPORIN LIKE 2; NUPL2; NY; OGDH; OXOGLUTARATE (ALPHA-KETOGLUTARATE) DEHYDROGENASE (LIPOAMIDE); P-VALUE; PARTICULATE MATTER; PB; PB(C(2)H(3)O(2))(2)·3H(2)O; PBS; PCR; PGM3; PHACTR2; PHOSPHATASE AND ACTIN REGULATOR 2; PHOSPHATE-BUFFERED SALINE; PHOSPHOGLUCOMUTASE 3; PLEXIN A2; PLXNA2; PM; POLYMERASE CHAIN REACTION; POTASSIUM VOLTAGE-GATED CHANNEL SHAL-RELATED SUBFAMILY MEMBER 2; PPP2CB; PROBABILITY VALUE; PROTEIN PHOSPHATASE 2 CATALYTIC SUBUNIT BETA ISOZYME; RAB30; RAB30 MEMBER RAS ONCOGENE FAMILY; RAP2B; RAP2B MEMBER RAS ONCOGENE FAMILY; REACTIVE OXYGEN SPECIES; RECEPTOR-INTERACTING SERINE-THREONINE KINASE 4; REVERSE TRANSCRIPTION QUANTITATIVE POLYMERASE CHAIN REACTION; RIBONUCLEIC ACID; RIPK4; RNA; ROS; RT-QPCR; SDS; SERINE DEHYDRATASE; SERINE/THREONINE KINASE 4; SFN; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; SLC1A1; SMALL ARFGAP 1; SMAP1; SODIUM META-ARSENITE; SODIUM VANADATE; SOLUTE CARRIER FAMILY 1 MEMBER 1; SP1; SP1 TRANSCRIPTION FACTOR; SPAM1; SPERM ADHESION MOLECULE 1; SRXN1; STAG2; STAT3; STK4; STRATIFIN; STROMAL ANTIGEN 2; SULFIREDOXIN 1; T LYMPHOCYTE CELL LINE; T4; TAQMAN LOW DENSITY ARRAY; THYMIDINE KINASE 6 CELL LINE; TIO(2); TITANIUM DIOXIDE; TK6; TLDA; UNTRANSLATED REGION; UTR; WI; WISCONSIN; ZIRCONIUM DIOXIDE; ZRO(2);

ANIMALS; ARSENITES; BALB 3T3 CELLS; CADMIUM CHLORIDE; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEALTH; METALS; MICE; MICROARRAY ANALYSIS; MICRORNAS; ORGANOMETALLIC COMPOUNDS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SODIUM COMPOUNDS; TOXICITY TESTS;

EID: 84887617557     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.09.049     Document Type: Article

References (55)

1. Arita A., Costa M. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 2009, 1:222-228. 10.1039/b903049b.
2. ATSDR Interaction Profile for: Arsenic, Cadmium, Chromium and Lead 2004, 160. U.S. Deparment of Health and Human Services Public Health Service. Agency for Toxic Substances and Disease Registry.
3. Bae D.S., Hanneman W.H., Yang R.S., Campain J.A. Characterization of gene expression changes associated with MNNG, arsenic, or metal mixture treatment in human keratinocytes: application of cDNA microarray technology. Environ. Health Perspect. 2002, 110(Suppl. 6):931-941.
4. Betel D., Wilson M., Gabow A., Marks D.S., Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008, 36:D149-D153. 10.1093/nar/gkm995.
5. Betel D., Koppal A., Agius P., Sander C., Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. Cell 2005, 120:15-20. 10.1186/gb-2010-11-8-r90, 10.1016/j.cell.2004.12.035.
6. Bollati V., et al. Exposure to metal-rich particulate matter modifies the expression of candidate microRNAs in peripheral blood leukocytes. Environ. Health Perspect. 2010, 118:763-768. 10.1289/ehp.0901300.
7. Cao Y., et al. MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. Tumour Biol. 2011, 32:179-188. 10.1007/s13277-010-0111-z.
8. Catto J.W., et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur. Urol. 2011, 59:671-681. 10.1016/j.eururo.2011.01.044.
9. Chira P., Vareli K., Sainis I., Papandreou C., Briasoulis E. Alterations of microRNAs in solid cancers and their prognostic value. Cancers 2010, 2:1328-1353. 10.3390/cancers2021328.
10. Choudhuri S. Small noncoding RNAs: biogenesis, function, and emerging significance in toxicology. J. Biochem. Mol. Toxicol. 2010, 24:195-216. 10.1002/jbt.20325.
11. de Souza Rocha Simonini P., et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res. 2010, 70:9175-9184. 10.1158/0008-5472.CAN-10-1318.
12. Dweep H., Sticht C., Pandey P., Gretz N. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J. Biomed. Inform. 2011, 44:839-847. 10.1016/j.jbi.2011.05.002.
13. Eppig J.T., et al. The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse. Nucleic Acids Res. 2012, 40:D881-D886. 10.1093/nar/gkr974.
14. Fabbri M., Urani C., Sacco M.G., Procaccianti C., Gribaldo L. Whole genome analysis and microRNAs regulation in HepG2 cells exposed to cadmium. Altex 2012, 29:173-182.
15. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79:351-379. 10.1146/annurev-biochem-060308-103103.
16. Farraj A.K., et al. ST depression, arrhythmia, vagal dominance, and reduced cardiac micro-RNA in particulate-exposed rats. Am. J. Respir. Cell Mol. Biol. 2011, 44:185-196. 10.1165/rcmb.2009-0456OC.
17. Fu S.W., Chen L., Man Y.G. miRNA biomarkers in breast cancer detection and management. J. Cancer 2011, 2:116-122.
18. Hengstler J.G., Bolt H.M.A. Special issue on metal toxicity. Arch. Toxicol. 2008, 82:489-491. 10.1007/s00204-008-0333-7.
19. Hou L., Wang D., Baccarelli A. Environmental chemicals and microRNAs. Mutat. Res. 2011, 714:105-112. 10.1016/j.mrfmmm.2011.05.004.
20. Huang Y., et al. Biological functions of microRNAs: a review. J. Physiol. Biochem. 2011, 67:129-139. 10.1007/s13105-010-0050-6.
21. Huntzinger E., Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat. Rev. Genet. 2011, 12:99-110. 10.1038/nrg2936.
22. Izzotti A., et al. Interplay between histopathological alterations, cigarette smoke and chemopreventive agents in defining microRNA profiles in mouse lung. Mutat. Res. 2011, 717:17-24. 10.1016/j.mrfmmm.2010.10.003.
23. Jost D., Nowojewski A., Levine E. Small RNA biology is systems biology. BMB Rep. 2011, 44:11-21. 10.5483/BMBRep.2011.44.1.11.
24. Kaikkonen M.U., Lam M.T., Glass C.K. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc. Res. 2011, 90:430-440. 10.1093/cvr/cvr097.
25. Kapushesky M., et al. Gene expression atlas at the European Bioinformatics Institute. Nucleic Acids Res. 2010, 38:D690-D698. 10.1093/nar/gkp936.
26. Kong A.P., et al. Associations between microRNA (miR-21, 126, 155 and 221), albuminuria and heavy metals in Hong Kong Chinese adolescents. Clin. Chim. Acta 2012, 413:1053-1057. 10.1016/j.cca.2012.02.014.
27. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610. 10.1038/nrg2843.
28. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets 120, 15-20.
29. Li N., et al. Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett. 2012, 586:722-728. 10.1016/j.febslet.2012.01.025.
30. Lu Y.C., et al. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev. Res. 2012, 5:665-674. 10.1158/1940-6207.CAPR-11-0358.
31. Lukiw W.J., Pogue A.I. Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells. J. Inorg. Biochem. 2007, 101:1265-1269. 10.1016/j.jinorgbio.2007.06.004.
32. Lukiw W.J., Dua P., Pogue A.I., Eicken C., Hill J.M. Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome. J. Toxic. Environ. Health A 2011, 74:1460-1468. 10.1080/15287394.2011.618973.
33. Lund A.H. miR-10 in development and cancer. Cell Death Differ. 2010, 17:209-214. 10.1038/cdd.2009.58.
34. Machova Polakova K., et al. Expression patterns of microRNAs associated with CML phases and their disease related targets. Mol. Cancer 2011, 10:41. 10.1186/1476-4598-10-41.
35. Madden E.F. The role of combined metal interactions in metal carcinogenesis: a review. Rev. Environ. Health 2003, 18:91-109.
36. Mahony S., Corcoran D.L., Feingold E., Benos P.V. Regulatory conservation of protein coding and microRNA genes in vertebrates: lessons from the opossum genome. Genome Biol. 2007, 8:R84. 10.1186/gb-2007-8-5-r84.
37. Marsit C.J., Eddy K., Kelsey K.T. MicroRNA responses to cellular stress. Cancer Res. 2006, 66:10843-10848. 10.1158/0008-5472.CAN-06-1894.
38. Martin Silva A., Emilio Rojas, Mahara Valverde Role of oxidative stress in transformation induced by metal mixture. Oxidative Med. Cell. Longev. 2011, 935160. 10.1155/2011/935160.
39. Nishikawa E., et al. miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res. 2011, 71:6165-6173. 10.1158/0008-5472.CAN-11-1020.
40. Ooi A.T., et al. Identification of an interleukin 13-induced epigenetic signature in allergic airway inflammation. Am. J. Transl. Res. 2012, 4:219-228.
41. Palmieri A., et al. Short-period effects of zirconia and titanium on osteoblast microRNAs. Clin. Implant. Dent. Relat. Res. 2008, 10:200-205. 10.1111/j.1708-8208.2007.00078.x.
42. Pohl H.R., Roney N., Wilbur S., Hansen H., De Rosa C.T. Six interaction profiles for simple mixtures. Chemosphere 2003, 53:183-197. 10.1016/S0045-6535(03)00436-3.
43. Poy M.N., et al. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:5813-5818. 10.1073/pnas.0810550106.
44. Rohrbeck A., et al. Toxicogenomics applied to in vitro carcinogenicity testing with Balb/c 3T3 cells reveled a gene signature predictive of chemical carcinogens. Toxicol. Sci. 2010, 118:31-41. 10.1093/toxsci/kfq246.
45. Safran M., et al. GeneCards Version 3: the human gene integrator. Database (Oxford) 2010, 2010:baq020. 10.1093/database/baq020.
46. Salnikow K., Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem. Res. Toxicol. 2008, 21:28-44. 10.1021/tx700198a.
47. Sen B., Mahadevan B., DeMarini D.M. Transcriptional responses to complex mixtures: a review. Mutat. Res. 2007, 636:144-177. 10.1016/j.mrrev.2007.08.002.
48. Singh B., Arlinghaus R.B. Mos and the cell cycle. Prog. Cell Cycle Res. 1997, 3:251-259.
49. Tian Y., et al. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J. Biol. Chem. 2010, 285:7986-7994. 10.1074/jbc.M109.062877.
50. Varnholt H. The role of microRNAs in primary liver cancer. Ann. Hepatol. 2008, 7:104-113.
51. Wang X. miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 2008, 14:1012-1017. 10.1261/rna.965408.
52. Wang G., Fowler B.A. Roles of biomarkers in evaluating interactions among mixtures of lead, cadmium and arsenic. Toxicol. Appl. Pharmacol. 2008, 233:92-99. 10.1016/j.taap.2008.01.017.
53. Xiao J., et al. MiR-204 regulates cardiomyocyte autophagy induced by ischemia-reperfusion through LC3-II. J. Biomed. Sci. 2011, 18:35. 10.1186/1423-0127-18-35.
54. Yu B., et al. miR-221 and miR-222 promote Schwann cell proliferation and migration by targeting LASS2 after sciatic nerve injury. J. Cell Sci. 2012, 125:2675-2683. 10.1242/jcs.098996.
55. Zhu H., Fan G.C. Role of microRNAs in the reperfused myocardium towards post-infarct remodelling. Cardiovasc. Res. 2012, 94:284-292. 10.1093/cvr/cvr291.